ChatGPT Summaries
Network analysis of extraintestinal manifestations and associated autoimmune disorders in Crohn’s disease and ulcerative colitisnpj Digital Medicine - (Wednesday April 16, 2025) - AI/ Frequent Updates/ npj Digital Medicine | |
 | We detect and interactively visualize occurrence, frequency, sequence, and clustering of extraintestinal manifestations (EIM) and associated immune disorders (AID) in 30,334 inflammatory bowel disease (IBD) patients (Crohn’s disease (CD) n = 15924, ulcerative colitis (UC) n = 11718,...
|
News 4/16/25HIStalk - (Wednesday April 16, 2025) - Daily Reads/ HIStalk | |
 | Top NewsKidney care company DaVita works to recover from a weekend ransomware attack that encrypted some of its systems. The attack was disclosed in an SEC filing. The company operates 2,657 outpatient dialysis centers...
|
Click Therapeutics granted FDA market authorization for digital migraine drugMobiHealthNews - (Tuesday April 15, 2025) - Frequent Updates/ MobiHealthNews | |
 | Digital therapeutic company Click Therapeutics was granted FDA marketing authorization for its prescription digital therapeutic for the preventive treatment of episodic migraines.The de novo classification is for the company’s CT-132 offering, which it received...
|
Reimagine Care, MedStar Health partner to integrate oncology care platformMobiHealthNews - (Tuesday April 15, 2025) - Frequent Updates/ MobiHealthNews | |
 | Home care cancer-focused platform Reimagine Care announced it is joining forces with healthcare system MedStar Health to integrate its on-demand oncology care platform into the health system's cancer care delivery model and assist patients...
|
Phantom Neuro secures $19M to advance human-machine technologyMobiHealthNews - (Tuesday April 15, 2025) - Frequent Updates/ MobiHealthNews | |
 | Phantom Neuro, a neurotechnology company that offers a muscle machine interface for controlling prosthetic limbs and robotic exoskeletons, announced an oversubscribed $19 million Series A funding round, bringing its total raise to $28 million.Ottobock...
|
Hackensack Meridian Chief AI Officer on the intersection of business and technologyHealthcare IT news - (Tuesday April 15, 2025) - Frequent Updates/ Healthcare IT News | |
 | Editor's Note: This is the sixth in our series on Chief AI Officers in Healthcare. Other recent CAIO profiles include Dennis Chornenky at UC Davis Health, Dr. Karandeep Singh at UC San Diego Health,...
|
World’s First AI Lung Sound Suite: TytoCare Gets FDA Clearance for RhonchiHIT Consultant - (Tuesday April 15, 2025) - AI/ Digital Health/ Frequent Updates/ HIT Consultant | |
 | TytoCare lung examWhat You Should Know: – TytoCare, a pioneering virtual care company dedicated to delivering accessible, high-quality primary care from the comfort of home announced the company has become the first in the world...
|
Prompt Engineering in Healthcare: Best Practices, Strategies and TrendsHealthTech Magazine - (Tuesday April 15, 2025) - Frequent Updates/ HealthTech Magazine | |
 | What Is Prompt Engineering in Healthcare? Prompt engineering is the process of telling an AI solution what to do and how to do it. Using precise and effective natural language prompts, users provide the LLM...
|
Sware & Salesforce Partner to Bring AI-Driven Technology to the Life Sciences CloudHIT Consultant - (Tuesday April 15, 2025) - Frequent Updates/ HIT Consultant | |
 | What You Should Know:– Sware, the leading provider of comprehensive GxP validation solutions for innovative life sciences and technology companies, today announced that it will deliver GxP computer systems validation of Salesforce Life Sciences Cloud. – Life...
|
Click Therapeutics Obtains FDA Authorization for First Prescription Digital Therapeutic for Migraine PreventionHIT Consultant - (Tuesday April 15, 2025) - Frequent Updates/ HIT Consultant | |
 | What You Should Know: – Click Therapeutics, Inc. (“Click”), a leader in the rapidly evolving field of prescription medical treatments, encompassing both prescription digital therapeutics (PDTs) and software-enhanced drug™ therapies has received FDA marketing authorization...
|